Awakn: Welcoming a new era of psychedelic-assisted therapy

Research Outreach interviews Ben Sessa, co-founder and Head of Psychedelic medicine at Awakn Life Sciences about his academic research and work with psychedelic-assisted therapy using ketamine.

Dr Ben Sessa is a psychiatrist, researcher, writer, and Co-founder and Head of Psychedelic Medicine at Awakn Life Sciences. His academic research coupled with his therapeutic practice have yielded vital insights into the safety and efficacy of psychedelic-assisted therapy. Now, practicing with the biotechnology company Awakn Life Sciences, he is working to increase the availability of these revolutionary treatments. As […]

Read More… from Awakn: Welcoming a new era of psychedelic-assisted therapy

Frailty screening: Doing good and avoiding harm

Worldwide, the number and proportion of older people in the population is increasing.

Ageing populations bring both opportunities and challenges for the economy, services and society. Screening for frailty aims to match the healthcare offered with a person’s needs, circumstances and capacity to benefit. Professors Mary McNally, Lynette Reid and William Lahey from Dalhousie University, Nova Scotia, Canada, explore the legal and ethical implications of frailty screening to ensure concerns with both doing […]

Read More… from Frailty screening: Doing good and avoiding harm